- Samsung SDI reported an operating loss of 256.7 billion won in the fourth quarter of 2025.
- This result contrasts sharply with the previous year’s profit of 311.79 billion won for the same period.
- The reported loss exceeded market estimations, which projected an operating loss of only 2.85 billion won.
- The company also posted a net loss of 226.5 billion won, a significant downturn from the 496.22 billion won profit a year earlier.
- Market expectations had anticipated a net profit of 182.87 billion won.
- Total sales decreased by 33% year-over-year, coming in at 3.75 trillion won for the quarter.
- Investor sentiment around Samsung SDI remains mixed, with 27 buy ratings, 3 hold ratings, and 2 sell ratings from analysts.
A look at Samsung SDI Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 4 | |
| Resilience | 3 | |
| Momentum | 2 | |
| OVERALL SMART SCORE | 3.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Samsung SDI is positioned for a positive long-term outlook. With strong scores in value, growth, and resilience, the company showcases promising fundamentals. Samsung SDI specializes in developing Lithium Ion Battery (LIB) technology, along with manufacturing a range of electronic components. Its focus on innovation and growth potential bodes well for its future prospects.
Despite lower scores in dividend and momentum, Samsung SDI‘s overall outlook remains optimistic. The company’s diverse product portfolio, including components for cellular phones, Energy Storage Systems, and solar panels, positions it well in the evolving tech industry. Investors may find Samsung SDI attractive for its solid value, growth opportunities, and resilience in the market.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
